1 |
Ma C, Li H, Lu S, Li X, Wang S, Wang W. Tryptase and Exogenous Trypsin: Mechanisms and Ophthalmic Applications. J Inflamm Res 2023;16:927-39. [PMID: 36891173 DOI: 10.2147/JIR.S402900] [Reference Citation Analysis]
|
2 |
Weller SR, Burnell JE, Aho BM, Obeng B, Ledue EL, Shim JK, Hess ST, Gosse JA. Mechanisms of Antimicrobial Agent Cetylpyridinium Chloride Mitochondrial Toxicity in Rodent and Primary Human Cells: Super-resolution Microscopy Reveals Nanostructural Disruption.. [DOI: 10.1101/2022.09.27.509813] [Reference Citation Analysis]
|
3 |
Saw PE, Chen J, Song E. Targeting CAFs to overcome anticancer therapeutic resistance. Trends Cancer 2022:S2405-8033(22)00055-3. [PMID: 35331673 DOI: 10.1016/j.trecan.2022.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
4 |
Umur N, İldan Çalım S, Yazıcı GN, Gurgen SG. Investigation of the effect of metoclopramide on proliferation signal molecules in breast tissue. Int J Exp Pathol 2022. [PMID: 35243705 DOI: 10.1111/iep.12433] [Reference Citation Analysis]
|
5 |
Jin S, Liu C, Shi G, Mu Y, Zhang H, Zhu Y, Su H, Ye D. IL-1A is associated with postoperative survival and immune contexture in clear cell renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations 2022;40:111.e1-111.e9. [DOI: 10.1016/j.urolonc.2021.11.029] [Reference Citation Analysis]
|
6 |
Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 2021;20:131. [PMID: 34635121 DOI: 10.1186/s12943-021-01428-1] [Cited by in Crossref: 102] [Cited by in F6Publishing: 125] [Article Influence: 51.0] [Reference Citation Analysis]
|
7 |
Ribatti D, Annese T, Tamma R. Controversial role of mast cells in breast cancer tumor progression and angiogenesis. Clin Breast Cancer 2021:S1526-8209(21)00246-9. [PMID: 34580034 DOI: 10.1016/j.clbc.2021.08.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
8 |
Moradi Tabriz H, Obohat M, Vahedifard F, Eftekharjavadi A. Survey of Mast Cell Density in Transitional Cell Carcinoma. Iran J Pathol 2021;16:119-27. [PMID: 33936222 DOI: 10.30699/IJP.2020.123562.2345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
9 |
Olivera A, Rivera J. Paradigm Shifts in Mast Cell and Basophil Biology and Function: An Emerging View of Immune Regulation in Health and Disease. Methods Mol Biol 2020;2163:3-31. [PMID: 32766962 DOI: 10.1007/978-1-0716-0696-4_1] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
10 |
Xu J, Zhang H, Li C, Du H, Shu M, Jia J. Activation of PLCγ/AKT/IκBα/p65 signaling increases inflammation in mast cells to promote growth of cutaneous neurofibroma. Life Sci 2019;239:117079. [PMID: 31756343 DOI: 10.1016/j.lfs.2019.117079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
11 |
Espinoza-Sánchez NA, Götte M. Role of cell surface proteoglycans in cancer immunotherapy. Semin Cancer Biol 2020;62:48-67. [PMID: 31336150 DOI: 10.1016/j.semcancer.2019.07.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
|
12 |
Derakhshani A, Vahidian F, Alihasanzadeh M, Mokhtarzadeh A, Lotfi Nezhad P, Baradaran B. Mast cells: A double-edged sword in cancer. Immunol Lett 2019;209:28-35. [PMID: 30905824 DOI: 10.1016/j.imlet.2019.03.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 9.5] [Reference Citation Analysis]
|
13 |
Plotkin JD, Elias MG, Fereydouni M, Daniels-Wells TR, Dellinger AL, Penichet ML, Kepley CL. Human Mast Cells From Adipose Tissue Target and Induce Apoptosis of Breast Cancer Cells. Front Immunol 2019;10:138. [PMID: 30833944 DOI: 10.3389/fimmu.2019.00138] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
14 |
Shimbori C, Upagupta C, Forsythe P, Kolb M. The Role of Mast Cells in the Pathophysiology of Pulmonary Fibrosis. Molecular and Translational Medicine 2019. [DOI: 10.1007/978-3-319-98143-7_6] [Reference Citation Analysis]
|
15 |
Yu Y, Blokhuis BRJ, Diks MAP, Keshavarzian A, Garssen J, Redegeld FA. Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells. Front Immunol 2018;9:2138. [PMID: 30294327 DOI: 10.3389/fimmu.2018.02138] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
|
16 |
Fujii K. New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma. Front Oncol 2018;8:198. [PMID: 29915722 DOI: 10.3389/fonc.2018.00198] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
|
17 |
Longo V, Tamma R, Brunetti O, Pisconti S, Argentiero A, Silvestris N, Ribatti D. Mast cells and angiogenesis in pancreatic ductal adenocarcinoma. Clin Exp Med 2018;18:319-23. [PMID: 29492715 DOI: 10.1007/s10238-018-0493-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
|
18 |
Milliat F, François A. [The roles of mast cells in radiation-induced damage are still an enigma]. Med Sci (Paris) 2018;34:145-54. [PMID: 29451485 DOI: 10.1051/medsci/20183402012] [Reference Citation Analysis]
|
19 |
Matsuda K, Okamoto N, Kondo M, Arkwright PD, Karasawa K, Ishizaka S, Yokota S, Matsuda A, Jung K, Oida K, Amagai Y, Jang H, Noda E, Kakinuma R, Yasui K, Kaku U, Mori Y, Onai N, Ohteki T, Tanaka A, Matsuda H. Mast cell hyperactivity underpins the development of oxygen-induced retinopathy. J Clin Invest 2017;127:3987-4000. [PMID: 28990934 DOI: 10.1172/JCI89893] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
20 |
Roy A, Libard S, Weishaupt H, Gustavsson I, Uhrbom L, Hesselager G, Swartling FJ, Pontén F, Alafuzoff I, Tchougounova E. Mast Cell Infiltration in Human Brain Metastases Modulates the Microenvironment and Contributes to the Metastatic Potential. Front Oncol 2017;7:115. [PMID: 28626727 DOI: 10.3389/fonc.2017.00115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
21 |
Lin C, Liu H, Zhang H, Cao Y, Li R, Wu S, Li H, He H, Xu J, Sun Y. Tryptase expression as a prognostic marker in patients with resected gastric cancer. Br J Surg 2017;104:1037-44. [PMID: 28542986 DOI: 10.1002/bjs.10546] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
22 |
Muntimadugu E, Kommineni N, Khan W. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy. Pharmacol Res 2017;126:109-22. [PMID: 28511988 DOI: 10.1016/j.phrs.2017.05.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 7.8] [Reference Citation Analysis]
|
23 |
Kountouras J, Boziki M, Polyzos SA, Katsinelos P, Gavalas E, Zeglinas C, Tzivras D, Romiopoulos I, Giorgakis N, Anastasiadou K, Vardaka E, Kountouras C, Kazakos E, Xiromerisiou G, Dardiotis E, Deretzi G. Impact of reactive oxygen species generation on Helicobacter pylori -related extragastric diseases: a hypothesis. Free Radical Research 2017;51:73-9. [DOI: 10.1080/10715762.2016.1271122] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
|
24 |
Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Wang Z, Xie H, Dai B, Xu J, Ye D. Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma. Ann Surg Oncol 2017;24:1435-42. [PMID: 27896514 DOI: 10.1245/s10434-016-5702-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
|
25 |
van Schaarenburg RA, Suurmond J, Habets KL, Brouwer MC, Wouters D, Kurreeman FA, Huizinga TW, Toes RE, Trouw LA. The production and secretion of complement component C1q by human mast cells. Mol Immunol 2016;78:164-70. [PMID: 27648858 DOI: 10.1016/j.molimm.2016.09.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
|
26 |
Sharma SH, Thulasingam S, Nagarajan S. Chemopreventive agents targeting tumor microenvironment. Life Sciences 2016;145:74-84. [DOI: 10.1016/j.lfs.2015.12.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
|
27 |
Leporini C, Ammendola M, Marech I, Sammarco G, Sacco R, Gadaleta CD, Oakley C, Russo E, De Sarro G, Ranieri G. Targeting mast cells in gastric cancer with special reference to bone metastases. World J Gastroenterol 2015; 21(37): 10493-10501 [PMID: 26457010 DOI: 10.3748/wjg.v21.i37.10493] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
28 |
Andersen MD, Kamper P, Nielsen PS, Bendix K, Riber-hansen R, Steiniche T, Hamilton-dutoit S, Clausen M, d'Amore F. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome. Eur J Haematol 2016;96:252-9. [DOI: 10.1111/ejh.12583] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
|
29 |
Devetzoglou M, Vyzoukaki R, Kokonozaki M, Xekalou A, Pappa CA, Papadopoulou A, Alegakis A, Androulakis N, Alexandrakis MG. High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity. Tumour Biol 2015;36:8491-7. [PMID: 26026586 DOI: 10.1007/s13277-015-3586-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
30 |
Olivera A, Rivera J. Paradigm shifts in mast cell and basophil biology and function: an emerging view of immune regulation in health and disease. Methods Mol Biol 2014;1192:3-31. [PMID: 25149480 DOI: 10.1007/978-1-4939-1173-8_1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
31 |
Miyagaki T, Sugaya M. Immunological milieu in mycosis fungoides and Sézary syndrome. J Dermatol 2014;41:11-8. [PMID: 24438139 DOI: 10.1111/1346-8138.12305] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
|
32 |
Galli SJ, Tsai M, Marichal T, Tchougounova E, Reber LL, Pejler G. Approaches for analyzing the roles of mast cells and their proteases in vivo. Adv Immunol 2015;126:45-127. [PMID: 25727288 DOI: 10.1016/bs.ai.2014.11.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 9.6] [Reference Citation Analysis]
|
33 |
Azouz NP, Fukuda M, Rothenberg ME, Sagi-Eisenberg R. Investigating mast cell secretory granules; from biosynthesis to exocytosis. J Vis Exp 2015;:52505. [PMID: 25651037 DOI: 10.3791/52505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
34 |
Groot Kormelink T, Powe DG, Kuijpers SA, Abudukelimu A, Fens MH, Pieters EH, Kassing van der Ven WW, Habashy HO, Ellis IO, Blokhuis BR, Thio M, Hennink WE, Storm G, Redegeld FA, Schiffelers RM. Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation. Oncotarget 2014;5:3159-67. [PMID: 24931643 DOI: 10.18632/oncotarget.1868] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
|
35 |
Siebenhaar F, Metz M, Maurer M. Mast cells protect from skin tumor development and limit tumor growth during cutaneous de novo carcinogenesis in a Kit-dependent mouse model. Exp Dermatol 2014;23:159-64. [PMID: 24444017 DOI: 10.1111/exd.12328] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
|
36 |
Ammendola M, Leporini C, Marech I, Gadaleta CD, Scognamillo G, Sacco R, Sammarco G, De Sarro G, Russo E, Ranieri G. Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy. Biomed Res Int. 2014;2014:154702. [PMID: 25295247 DOI: 10.1155/2014/154702] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
|
37 |
Marech I, Ammendola M, Sacco R, Capriuolo GS, Patruno R, Rubini R, Luposella M, Zuccalà V, Savino E, Gadaleta CD. Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: possible translational significance. BMC Cancer. 2014;14:534. [PMID: 25056597 DOI: 10.1186/1471-2407-14-534] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
|
38 |
Marech I, Ammendola M, Gadaleta C, Zizzo N, Oakley C, Gadaleta CD, Ranieri G. Possible biological and translational significance of mast cells density in colorectal cancer. World J Gastroenterol 2014; 20(27): 8910-8920 [PMID: 25083063 DOI: 10.3748/wjg.v20.i27.8910] [Cited by in F6Publishing: 33] [Reference Citation Analysis]
|
39 |
Sharma N, Everingham S, Ramdas B, Kapur R, Craig AW. SHP2 phosphatase promotes mast cell chemotaxis toward stem cell factor via enhancing activation of the Lyn/Vav/Rac signaling axis. J Immunol 2014;192:4859-66. [PMID: 24733849 DOI: 10.4049/jimmunol.1301155] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
|
40 |
Luo R, Wang X, Dong Y, Wang L, Tian C. Activation of protease-activated receptor 2 reduces glioblastoma cell apoptosis. J Biomed Sci 2014;21:25. [PMID: 24670244 DOI: 10.1186/1423-0127-21-25] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
41 |
Krstic J, Santibanez JF. Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. ScientificWorldJournal 2014;2014:521754. [PMID: 24578639 DOI: 10.1155/2014/521754] [Cited by in Crossref: 98] [Cited by in F6Publishing: 111] [Article Influence: 10.9] [Reference Citation Analysis]
|
42 |
Taverna G, Giusti G, Seveso M, Hurle R, Colombo P, Stifter S, Grizzi F. Mast cells as a potential prognostic marker in prostate cancer. Dis Markers 2013;35:711-20. [PMID: 24324287 DOI: 10.1155/2013/478303] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
|
43 |
Ribatti D. Angiogenesis as a treatment target in leukemia. International Journal of Hematologic Oncology 2013;2:229-42. [DOI: 10.2217/ijh.13.18] [Reference Citation Analysis]
|
44 |
Chimal-Ramírez GK, Espinoza-Sánchez NA, Fuentes-Pananá EM. Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion. J Oncol 2013;2013:835956. [PMID: 23577028 DOI: 10.1155/2013/835956] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
|
45 |
Gupta K. Iatrogenic Angiogenesis. Morphine and Metastasis 2013. [DOI: 10.1007/978-94-007-5678-6_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
46 |
Ni Z, Tao K, Chen G, Chen Q, Tang J, Luo X, Yin P, Tang J, Wang X. CLPTM1L is overexpressed in lung cancer and associated with apoptosis. PLoS One 2012;7:e52598. [PMID: 23300716 DOI: 10.1371/journal.pone.0052598] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
|
47 |
Jeong HJ, Oh HA, Nam SY, Han NR, Kim YS, Kim JH, Lee SJ, Kim MH, Moon PD, Kim HM, Oh HA. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth. Int J Cancer 2013;132:2492-501. [PMID: 23161568 DOI: 10.1002/ijc.27937] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
|
48 |
Reber LL, Marichal T, Galli SJ. New models for analyzing mast cell functions in vivo. Trends Immunol 2012;33:613-25. [PMID: 23127755 DOI: 10.1016/j.it.2012.09.008] [Cited by in Crossref: 141] [Cited by in F6Publishing: 121] [Article Influence: 12.8] [Reference Citation Analysis]
|
49 |
Rabenhorst A, Schlaak M, Heukamp LC, Förster A, Theurich S, von Bergwelt-Baildon M, Büttner R, Kurschat P, Mauch C, Roers A, Hartmann K. Mast cells play a protumorigenic role in primary cutaneous lymphoma. Blood 2012;120:2042-54. [PMID: 22837530 DOI: 10.1182/blood-2012-03-415638] [Cited by in Crossref: 94] [Cited by in F6Publishing: 100] [Article Influence: 8.5] [Reference Citation Analysis]
|
50 |
de Souza DA Jr, Toso VD, Campos MR, Lara VS, Oliver C, Jamur MC. Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression. PLoS One 2012;7:e40790. [PMID: 22815822 DOI: 10.1371/journal.pone.0040790] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
|
51 |
Evans A, Costello E. The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion. Front Physiol. 2012;3:270. [PMID: 22969725 DOI: 10.3389/fphys.2012.00270] [Cited by in Crossref: 16] [Cited by in F6Publishing: 47] [Article Influence: 1.5] [Reference Citation Analysis]
|
52 |
Rudich N, Ravid K, Sagi-Eisenberg R. Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation. Front Immunol 2012;3:134. [PMID: 22675325 DOI: 10.3389/fimmu.2012.00134] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
|
53 |
Gilfillan AM, Beaven MA. Regulation of mast cell responses in health and disease. Crit Rev Immunol 2011;31:475-529. [PMID: 22321108 DOI: 10.1615/critrevimmunol.v31.i6.30] [Cited by in Crossref: 173] [Cited by in F6Publishing: 180] [Article Influence: 15.7] [Reference Citation Analysis]
|
54 |
Lunderius-Andersson C, Enoksson M, Nilsson G. Mast Cells Respond to Cell Injury through the Recognition of IL-33. Front Immunol 2012;3:82. [PMID: 22566963 DOI: 10.3389/fimmu.2012.00082] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
|
55 |
Caruso RA, Fedele F, Parisi A, Paparo D, Bonanno A, Finocchiaro G, Branca G, Scardigno M, Rigoli L. Chronic Allergic-like Inflammation in the Tumor Stroma of Human Gastric Carcinomas: An Ultrastructural Study. Ultrastructural Pathology 2012;36:139-44. [DOI: 10.3109/01913123.2012.656883] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
56 |
Carroll-Portillo A, Surviladze Z, Cambi A, Lidke DS, Wilson BS. Mast cell synapses and exosomes: membrane contacts for information exchange. Front Immunol 2012;3:46. [PMID: 22566928 DOI: 10.3389/fimmu.2012.00046] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 4.4] [Reference Citation Analysis]
|
57 |
Shaw JL, Ashoori F, Fakhri S, Citardi MJ, Luong A. Increased percentage of mast cells within sinonasal mucosa of chronic rhinosinusitis with nasal polyp patients independent of atopy. International Forum of Allergy & Rhinology 2012;2:233-40. [DOI: 10.1002/alr.21021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
|
58 |
dos Santos Costa Poggiani S, Maria Terra E, Torres Neto R, Tinucci Costa M, Laufer Amorim R. Canine Cutaneous Mast Cell Tumor: Biologic Behavior and Its Correlation with Prognostic Indicators. OJVM 2012;02:255-261. [DOI: 10.4236/ojvm.2012.24041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
59 |
Zhao YB, Wang JL, Wang GB. Roles of mast cells in gastric carcinogenesis. Shijie Huaren Xiaohua Zazhi 2011; 19(21): 2246-2250 [DOI: 10.11569/wcjd.v19.i21.2246] [Reference Citation Analysis]
|
60 |
Gilfillan AM, Austin SJ, Metcalfe DD. Mast cell biology: introduction and overview. Adv Exp Med Biol 2011;716:2-12. [PMID: 21713648 DOI: 10.1007/978-1-4419-9533-9_1] [Cited by in Crossref: 87] [Cited by in F6Publishing: 93] [Article Influence: 7.3] [Reference Citation Analysis]
|